Sign in
Taking people in United StatesNo phase

Studies how HIV infects blood cells in people with and without HIV

Studies blood cells and body fluids from adults with HIV or other immune conditions.

Key facts

Who runs it
National Institute of Allergy and Infectious Diseases (NIAID)
Where
Bethesda and Washington D.C., United StatesSee the 2 sites
Trial code
Registry title
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
Status
Recruiting
People taking part
2,419 people, planned
Started
9 Mar 1993
Type of study
Observational, 3 groups
Record updated
29 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults, both people living with HIV and people living without HIV, who will give blood samples to help study how HIV infection works.

Age
18 years or older (up to 120 years).
Sex
All sexes can join.

Main reasons for not taking part

  • Pregnant or breastfeeding women
  • Active substance abuse, or past substance abuse that could affect following the study or safety

The registry criteria, word for word

Show all 9 criteriaShow less

Who cannot take part

  • Active substance abuse or history of prior substance abuse that may interfere with protocol compliance or compromise volunteer safety
  • Pregnant and/or breastfeeding females

Other criteria

  • INCLUSION CRITERIA:
  • 18 years of age or older
  • Adequate venous access
  • Have a blood pressure less than or equal to 180/100: pulse rate 50-100, unless a lower pulse rate is considered normal for the volunteer
  • Have adequate blood counts (volunteers living with HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000; volunteers living without HIV: hemoglobin greater than or equal to 9.0 g/dL, platelets greater than or equal to 50,000
  • Be willing and able to provide written informed consent on screening, comply with study requirements and procedures, and comply with clinic policies
  • Willingness to allow blood samples to be used for future studies of HIV infection/pathogenesis, and undergo hepatitis screening

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 120 years old?

Where in United States

  • National Institutes of Health Clinical CenterBethesda, United StatesContact: Catherine A Seamon, R.N.Taking people
  • Washington Hospital CenterWashington D.C., United StatesContact: Catherine A Seamon, R.N.No longer taking part

About the trial

What the trial wants to find out

We are studying virologic and/or immunologic parameters of HIV infection and other infectious or non-infectious immune deficiency diseases in order to better understand the pathogenesis of HIV. Because of the lack of an adequate animal model it is generally necessary to utilize human peripheral blood cells for studying aspects of either in vivo or in vitro HIV infection. We wish to be able to continue to elucidate many pathogenic aspects of HIV infection in relation to other infectious or non-infectious immune regulation and dysregulation using human peripheral blood mononuclear cells as a model....

The 3 groups in the trial

  • Individuals living with/without HIV
  • Individuals living with/without infectious diseases

    Individuals living with/without infectious diseases of interest

  • Individuals with/without Immunodeficiencies

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
Plain-language title
Studies how HIV infects blood cells in people with and without HIVGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT00001281, who can take part
Record updated
29 October 2026